Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs
W Froestl, A Pfeifer, A Muhs - Journal of Alzheimer's Disease, 2013 - content.iospress.com
Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …
Anticancer effect of calycopterin via PI3K/Akt and MAPK signaling pathways, ROS-mediated pathway and mitochondrial dysfunction in hepatoblastoma cancer …
Calycopterin is a flavonoid compound isolated from Dracocephalum kotschyi that has
multiple medical uses, as an antispasmodic, analgesic, anti-hyperlipidemic, and …
multiple medical uses, as an antispasmodic, analgesic, anti-hyperlipidemic, and …
Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014
W Froestl, A Pfeifer, A Muhs - Journal of Alzheimer's Disease, 2014 - content.iospress.com
Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers,
are very productive. The review “Drugs interacting with Targets other than Receptors or …
are very productive. The review “Drugs interacting with Targets other than Receptors or …
Chaperones, protein homeostasis & protein aggregation diseases
M Minoia - 2014 - research.rug.nl
Proteins are the functional molecules of cells and have to be folded into a specific three-
dimensional structure. Besides being non-functional, non-folded proteins can easily clump …
dimensional structure. Besides being non-functional, non-folded proteins can easily clump …